Impax reshuffles its board as veteran chairman Keith Falconer steps down

Successor Sally Bridgeland has a long history in the pensions industry

|

Impax has reshuffled its board as Keith Falconer steps down as chairman after 16 years, effective today.

Sally Bridgeland (pictured), who has been a non-executive director since 2015, will succeed Falconer as chair. Bridgeland has a long history working in the pensions industry and was chief executive of the BP Pension Fund from 2007 to 2014.

Falconer noted Impax’s assets under management have grown from £59m to more than £23bn during his tenure as chairman.

“We have accomplished much through bull and bear markets and there have been many notable milestones. Over these years we’ve benefited from notably low staff turnover, our investment philosophy has become widely accepted and ever more compelling, and we have maintained and developed our strong corporate culture.”

Bridgeland is currently a non-executive director of Royal London and the Local Pensions Partnership.

She says she is assuming the role of Impax chair at an exciting time in its history.

“The commitment of policy makers, business leaders and wider society to forging a path towards a more sustainable economy has never been stronger.

“Against this backdrop, Impax’s well-established investment philosophy, broad range of investment solutions and acknowledged leadership position will stand the company in good stead to deliver further value to clients over the coming years.”

Following her promotion, Bridgeland has stepped down as chair of the audit and risk committee and will be replaced by Vince O’Brien. Lindsey Brace Martinez will replace O’Brien as chair of the remuneration committee.

Additionally, Simon O’Regan has been appointed non-executive director. O’Regan was previously chief executive of Mercer’s US business before his retirement in 2017.

Impax chief executive Ian Simm said: “Simon’s in-depth knowledge of international markets, including the United States, will be invaluable as we continue to develop our business globally.”

O’Regan will sit on the audit and risk and remuneration committees.

MORE ARTICLES ON